173 related articles for article (PubMed ID: 15899814)
1. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
[TBL] [Abstract][Full Text] [Related]
2. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
[TBL] [Abstract][Full Text] [Related]
3. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
Mishra L; Katuri V; Evans S
Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
[TBL] [Abstract][Full Text] [Related]
4. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
[TBL] [Abstract][Full Text] [Related]
5. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.
Engle SJ; Hoying JB; Boivin GP; Ormsby I; Gartside PS; Doetschman T
Cancer Res; 1999 Jul; 59(14):3379-86. PubMed ID: 10416598
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
[TBL] [Abstract][Full Text] [Related]
8. Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.
Redman RS; Katuri V; Tang Y; Dillner A; Mishra B; Mishra L
J Oral Pathol Med; 2005 Jan; 34(1):23-9. PubMed ID: 15610403
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta signaling in colon cancer cells.
Li F; Cao Y; Townsend CM; Ko TC
World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
[TBL] [Abstract][Full Text] [Related]
10. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.
Calonge MJ; Massagué J
J Biol Chem; 1999 Nov; 274(47):33637-43. PubMed ID: 10559252
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer.
Katuri V; Tang Y; Marshall B; Rashid A; Jogunoori W; Volpe EA; Sidawy AN; Evans S; Blay J; Gallicano GI; Premkumar Reddy E; Mishra L; Mishra B
Oncogene; 2005 Dec; 24(54):8012-24. PubMed ID: 16158060
[TBL] [Abstract][Full Text] [Related]
12. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
[TBL] [Abstract][Full Text] [Related]
13. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
14. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF.
Saha T; Vardhini D; Tang Y; Katuri V; Jogunoori W; Volpe EA; Haines D; Sidawy A; Zhou X; Gallicano I; Schlegel R; Mishra B; Mishra L
Oncogene; 2006 Feb; 25(5):693-705. PubMed ID: 16247473
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
Yan Z; Kim GY; Deng X; Friedman E
J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
[TBL] [Abstract][Full Text] [Related]
17. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
Müller N; Reinacher-Schick A; Baldus S; van Hengel J; Berx G; Baar A; van Roy F; Schmiegel W; Schwarte-Waldhoff I
Oncogene; 2002 Sep; 21(39):6049-58. PubMed ID: 12203117
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Hardwick JC; Van Den Brink GR; Bleuming SA; Ballester I; Van Den Brande JM; Keller JJ; Offerhaus GJ; Van Deventer SJ; Peppelenbosch MP
Gastroenterology; 2004 Jan; 126(1):111-21. PubMed ID: 14699493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
